Neue Suche | Kongressdetail
mail
Druckansicht
 
 

Adenosine-Pathway Targeted Cancer Immunotherapy

Evvnt Promotion / evvnt
-
10.05.2022 - 12.05.2022  Omni Parker House, 60 School Street, 02108 Boston, USA
Time: 09:00 - 15:30
 
Kongressthemen
Maximize the Clinical and Commercial Opportunity of the Adenosine-Pathway as a Second-generation Immuno-oncology Target.

Adenosine-pathway therapies have produced a plethora of promising clinical trial data that is being met with refreshed excitement, enthusiasm, and R and D investment for adenosine-pathway targets.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Arabella Young, Assistant Professor in the Department of Pathology; Investigator at the Huntsman Cancer Institute, The University of Utah, Bin Zhang, Professor, Northwestern University and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/974505-1?pid=4832
Frau Hollie Bulfin
 
Kategorien
Onkologie
Sprache
Englisch
Kongressgebühr
USD 2599.0 - USD 5846.0
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Anästhesie in Entwicklungsländern e. V.AMREF - African Medical and Research FoundationHilfswerk AustriaÄrzte der WeltHelix - Forschung & Beratung WienÖsterreichische Akademie der ÄrzteAlumni Club Medizinische Universität WienCenter of Excellence